Bavarian Nordic A/S (BVNRY) Q1 2026 Earnings Call Transcript
Bavarian Nordic A/S (BVNRY) Q4 2025 Earnings Call Transcript
Bavarian Nordic A/S (OTCPK:BVNRY) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Paul Chaplin - CEO & President Henrik Juuel - CFO & Executive VP Conference Call Participants Romy O'Connor - Van Lanschot Kempen NV Thomas Bowers - SEB, Research Division Lucy-Emma Codrington-Bartlett - Jefferies LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Bavarian Nordic Third Quarterly Report for the 9-month period ended 30th of September 2025 Conference Call on Webcast.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is how Bavarian Nordic (BVNRY) and Dare Bioscience, Inc. (DARE) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bavarian Nordic (BVNRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Shares of Bavarian Nordic surged in Danish trading Friday as investors bought into the company with the only approved mpox vaccine in the U.S. and Europe, after the World Health Organization (WHO) declared the fast-breaking outbreak a global health emergency.